The FDA on May 19 approved the first drug to treat patients with dystrophic epidermolysis bullosa — a rare genetic disorder that causes fragile skin and persistent sores.
Read the full post on Becker's Hospital Review - Healthcare News
FDA approves 1st drug for rare skin condition
